Biocon Ltd

BIOCON

Company Profile

  • Business description

    Biocon Ltd is a biopharmaceutical company engaged in the manufacture of biotechnology products, active pharmaceutical ingredients, and formulations, including biosimilar drugs for diabetes, oncology, autoimmune diseases, and ophthalmology, as well as research services. The Company focuses on the core therapeutic areas of diabetes, oncology and immunology. Its segments are Generics, Biosimilars, and CRDMO, with Biosimilars generating the maximum revenue. The Company also complies with Extended Producer Responsibility (EPR) obligations by integrating EPR considerations into packaging design, procurement practices, and vendor engagement processes. The Company generates a majority of its revenue from customers located in India, and the rest from Brazil, Singapore, and the rest of the world.

  • Contact

    20th KM, Hosur Road
    Electronics City
    BengaluruKA560100
    IND

    T: +91 8028082808

    https://www.biocon.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 March 2027

    Employees

    9,811

Stocks News & Analysis

stocks

ASX energy share undervalued ahead of earnings

Pricing strength outweighs temporary production headwinds.
stocks

Tesla: Reported China divestiture plan could clear path for SpaceX merger

Media report says Tesla is exploring divestiture plans to ease regulatory approval of a Tesla-SpaceX merger.
stocks

This onetime AI market darling is now surprisingly undervalued

This AI leader qualifies as a GARP stock today.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,178.4069.700.77%
CAC 408,613.82104.181.22%
DAX 4026,001.31372.071.45%
Dow JONES (US)52,988.47503.440.96%
FTSE 10010,857.7010.35-0.10%
HKSE26,009.40124.970.48%
NASDAQ25,893.77519.912.05%
Nikkei 22563,754.90607.12-0.94%
NZX 50 Index13,774.9375.650.55%
S&P 5007,588.9599.231.32%
S&P/ASX 2009,019.3070.300.79%
SSE Composite Index3,809.6622.60-0.59%

Market Movers